Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure
暂无分享,去创建一个
S. Selvaraj | S. Akers | J. Chirinos | B. Ansari | Jonathan Lee | J. M. Vanjarapu | Anupam Kumar | A. Suri | Jessica Kim | Sowmya Gaddam | S. Yenigalla | Dheera Tamvada | Bilal A Ansari
[1] R. John,et al. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation , 2017, Circulation. Heart failure.
[2] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[3] A. Bierhals,et al. Usefulness of Psoas Muscle Area Determined by Computed Tomography to Predict Mortality or Prolonged Length of Hospital Stay in Patients Undergoing Left Ventricular Assist Device Implantation. , 2016, The American journal of cardiology.
[4] F. Landi,et al. Sarcopenia in heart failure: mechanisms and therapeutic strategies , 2016, Journal of geriatric cardiology : JGC.
[5] R. Arena,et al. Bulking Up Skeletal Muscle to Improve Heart Failure Prognosis. , 2016, JACC. Heart failure.
[6] K. Kamiya,et al. Complementary Role of Arm Circumference to Body Mass Index in Risk Stratification in Heart Failure. , 2016, JACC. Heart failure.
[7] F. Flachskampf,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[8] M. Haykowsky,et al. High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. , 2015, Journal of applied physiology.
[9] A. Jette,et al. PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE. , 2015, The Journal of frailty & aging.
[10] J. Shuster,et al. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis , 2014, BMC Medicine.
[11] S. Bartels,et al. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III , 2014, European Journal of Clinical Nutrition.
[12] G. Azhar,et al. New Approaches to Treating Cardiac Cachexia in the Older Patient , 2013, Current Cardiovascular Risk Reports.
[13] W. Hundley,et al. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. , 2013, Journal of the American College of Cardiology.
[14] G. Onder,et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. , 2013, Age and ageing.
[15] S. Anker,et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). , 2013, European heart journal.
[16] S. Blair,et al. Effects of Muscular Strength on Cardiovascular Risk Factors and Prognosis , 2012, Journal of cardiopulmonary rehabilitation and prevention.
[17] U. Wisløff,et al. Exercise Training Prevents Oxidative Stress and Ubiquitin-Proteasome System Overactivity and Reverse Skeletal Muscle Atrophy in Heart Failure , 2012, PloS one.
[18] J. Little,et al. Exercise and nutritional interventions for improving aging muscle health , 2012, Endocrine.
[19] F. Iellamo,et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. , 2010, Journal of the American College of Cardiology.
[20] S. Anker,et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study , 2010, Journal of cachexia, sarcopenia and muscle.
[21] Douglas E Schaubel,et al. Sarcopenia and mortality after liver transplantation. , 2010, Journal of the American College of Surgeons.
[22] F. Iellamo,et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. , 2009, Journal of the American College of Cardiology.
[23] C. Opasich,et al. Adequate energy‐protein intake is not enough to improve nutritional and metabolic status in muscle‐depleted patients with chronic heart failure , 2008, European journal of heart failure.
[24] M. Cesari,et al. Target population for clinical trials on sarcopenia , 2008, The journal of nutrition, health & aging.
[25] P. Stenvinkel,et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. , 2007, The American journal of clinical nutrition.
[26] Robert Ross,et al. Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.
[27] Jeffrey M. Hausdorff,et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. , 2001, Journal of applied physiology.
[28] C. Baird. The pilot study. , 2000, Orthopedic nursing.
[29] R. Lenkinski,et al. Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure , 1992, Circulation.
[30] D. Houston,et al. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. , 2008, The American journal of clinical nutrition.